# 2024-31312: Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act

2024-31312, Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, is a Federal Register notice from an unnamed agency published 2025-01-03, effective 2025-05-15 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2024-31312
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2024-31312
- Title: Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act
- Type: Notice
- Agencies: unknown
- Citation: unknown
- Published: 2025-01-03
- Effective: 2025-05-15
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

The FDA is hosting a public meeting on May 15, 2025, to gather ideas from parents, doctors, drug makers, and others about improving medicines for kids. This helps the FDA write a report to Congress about making pediatric drugs safer and better labeled. You can join in person or online and send your thoughts by June 13, 2025—no money changes now, just your voice shaping the future!

## Abstract

The Food and Drug Administration's (FDA, Agency, or we) Office of Pediatric Therapeutics, the Center for Drug Evaluation and Research, and the Center for Biologics Evaluation and Research are announcing a public meeting entitled "Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act." The purpose of the public meeting is to seek input from interested parties, including patient/parent/ caregiver groups, consumer groups, regulated industry, academia, and others. This input will enable FDA to obtain any recommendations or information relevant to the report to Congress that FDA is required to submit concerning pediatric drug and biologic development and labeling, as outlined in section 508 of the Food and Drug Administration Safety and Innovation Act (FDASIA).

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20724](https://policyrisk.com/federal-register/2026-20724): Notice of Intent To Prepare a Supplemental Environmental Impact Statement for the Sentinel Deployment and Minuteman III Decommissioning and…, 2026-10-09
- [2026-20771](https://policyrisk.com/federal-register/2026-20771): Center for Scientific Review; Notice of Closed Meetings, 2026-10-09
- [2026-20708](https://policyrisk.com/federal-register/2026-20708): Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX…, 2026-10-09
- [2026-20710](https://policyrisk.com/federal-register/2026-20710): Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX…, 2026-10-09
- [2026-20779](https://policyrisk.com/federal-register/2026-20779): Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Revi…, 2026-10-09
- [2026-20763](https://policyrisk.com/federal-register/2026-20763): National Environmental Policy Act Implementing Procedures: Wintertime Oil and Gas Exploration in the National Petroleum Reserve in Alaska C…, 2026-10-09

## Sources
- [2024-31312 on federalregister.gov](https://www.federalregister.gov/documents/2025/01/03/2024-31312/interested-parties-meeting-implementation-of-the-best-pharmaceuticals-for-children-act-and-pediatric)
- [2024-31312 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-01-03/pdf/2024-31312.pdf)

## Related
- [Previous: 2024-31520, Submission for Review 3206-0253: Leadership Assessment Surveys](https://policyrisk.com/federal-register/2024-31520)
- [Next: 2024-31322, Notice of Availability of a Draft Programmatic Environmental Impact Statement f…](https://policyrisk.com/federal-register/2024-31322)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2024-31312 (as of 2026-06-08).